[1] Ritchie H, Mathieu E, Rodés-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, et al. Coronavirus pandemic (COVID-19). 2022. https://ourworldindata.org/coronavirus. [2022-3-5].https://ourworldindata.org/coronavirus
[2] Centre for Health Protection of the Department of Health, The Hospital Authority. Statistics on 5th wave of COVID-19. 2022. https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf. [2022-3-5]. (In Chinese). https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf
[3] Ministry of Health Government of Singapore. Update on local COVID-19 situation and vaccination progress (10 Aug 2021). 2021. https://www.moh.gov.sg/news-highlights/details/update-on-local-covid-19-situation-and-vaccination-progress-(10-aug-2021). [2022-3-5].https://www.moh.gov.sg/news-highlights/details/update-on-local-covid-19-situation-and-vaccination-progress-(10-aug-2021)
[4] O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou PJ, Chan KC, et al. Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized clinical trial. JAMA 2022;327(5):432 − 41. http://dx.doi.org/10.1001/jama.2021.24939CrossRef
[5] Breiman L. Random forests. Mach Learn 2001;45(1):5 − 32. http://dx.doi.org/10.1023/A:1010933404324CrossRef
[6] Wright MN, Ziegler A. Ranger: a fast implementation of random forests for high dimensional data in C++ and R. J Stat Softw 2017;77(1):1 − 17. http://dx.doi.org/10.18637/jss.v077.i01CrossRef
[7] COVID-19 Forecasting Team. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. Lancet 2022;399(10334):1469 − 88. http://dx.doi.org/10.1016/S0140-6736(21)02867-1CrossRef
[8] Bartleson JM, Radenkovic D, Covarrubias AJ, Furman D, Winer DA, Verdin E. SARS-CoV-2, COVID-19 and the aging immune system. Nat Aging 2021;1(9):769 − 82. http://dx.doi.org/10.1038/s43587-021-00114-7CrossRef
[9] Ranzani OT, Hitchings MDT, Dorion M, D'Agostini TL, de Paula RC, de Paula OFP, et al. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study. BMJ 2021;374:n2015. http://dx.doi.org/10.1136/bmj.n2015CrossRef
[10] McMenamin ME, Nealon J, Lin Y, Wong JY, Cheung JK, Lau EHY, et al. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study. Lancet Infect Dis. 2022 Jul 15:S1473-3099(22)00345-0. http://dx.doi.org/10.1016/S1473-3099(22)00345-0.http://dx.doi.org/10.1016/S1473-3099(22)00345-0